FDA Inspection
Abbvie Ireland NL B.V.Abbvie Ireland NL B.V. – FDA Inspection, Dec 14, 2022
Record Details
This FDA Inspection record concerns Abbvie Ireland NL B.V., with an inspection on December 14, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Abbvie Ireland NL B.V.
- Inspection Date
- December 14, 2022
- Product Type
- Drugs
View Company Profile
ID · ecd3cdcc-9f69-4553-b801-84bc390d600e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1253298
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Abbvie Ireland NL B.V.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| February 28, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 29, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 20, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 12, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 24, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Abbvie Ireland NL B.V.
- FDA Inspection 1124019 - 2020-02-28
- FDA Inspection 1105474 - 2019-08-29
- FDA Inspection 1000859 - 2017-01-20
- FDA Inspection 899864 - 2014-09-12
- FDA Inspection 717041 - 2011-03-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.